-
Je něco špatně v tomto záznamu ?
Ca2+ sensitization and Ca2+ entry in the control of blood pressure and adrenergic vasoconstriction in conscious Wistar-Kyoto and spontaneously hypertensive rats
M. Behuliak, M. Pintérová, M. Bencze, M. Petrová, S. Líšková, P. Karen, J. Kuneš, I. Vaněčková, J. Zicha,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- 1-(5-isochinolinsulfonyl)-2-methylpiperazin analogy a deriváty farmakologie MeSH
- 3-pyridinkarboxylová kyselina, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)fenyl)-, methyleste farmakologie MeSH
- adrenergní receptory metabolismus MeSH
- agonisté vápníkových kanálů farmakologie MeSH
- arteriae mesentericae účinky léků MeSH
- kinázy asociované s rho antagonisté a inhibitory metabolismus MeSH
- krevní tlak * MeSH
- krysa rodu rattus MeSH
- nifedipin farmakologie MeSH
- noradrenalin farmakologie MeSH
- oxid dusnatý metabolismus MeSH
- potkani inbrední SHR MeSH
- potkani inbrední WKY MeSH
- rhoA protein vázající GTP metabolismus MeSH
- teplota MeSH
- vápník metabolismus MeSH
- vápníkové kanály - typ L metabolismus MeSH
- vazokonstrikce účinky léků MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Calcium entry through nifedipine-sensitive L-type voltage-dependent calcium channels (L-VDCC) is augmented in spontaneously hypertensive rats (SHR) characterized by enhanced sympathetic vasoconstriction. However, the changes of calcium sensitization mediated by RhoA/Rho kinase pathway are less understood. METHODS AND RESULTS: The participation of calcium entry and calcium sensitization in the control of blood pressure (BP) and vascular contraction was studied in SHR and normotensive Wistar-Kyoto (WKY) rats. The acute administration of fasudil (Rho kinase inhibitor) caused BP decrease which lasted longer in SHR. Fasudil also attenuated adrenergic contraction in femoral or mesenteric arteries of WKY and SHR. BP reduction elicited by fasudil in WKY was more pronounced than that induced by L-VDCC blocker nifedipine (-33±2 vs. -15±3% of baseline BP, P<0.001), whereas both inhibitors were similarly effective in SHR (-36±4 vs. -41±2%). Fasudil pretreatment also attenuated BP elevation elicited by L-VDCC agonist BAY K8644 more in WKY than in SHR (-63±4 vs. -42±5%, P<0.001), indicating reduced calcium sensitization in SHR. Moreover, fasudil pretreatment shifted norepinephrine dose-response curves to the right more in WKY than in SHR. The additional nifedipine pretreatment shifted these curves further to the right but this shift was more pronounced in SHR than in WKY. Thus adrenergic vasoconstriction is more dependent on L-VDCC in SHR and on RhoA/Rho kinase pathway in WKY rats. CONCLUSION: Ca sensitization mediated by RhoA/Rho kinase pathway is attenuated in SHR compared with normotensive WKY rats. This might be a part of the compensation for enhanced Ca entry through L-VDCC in genetic hypertension.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14063909
- 003
- CZ-PrNML
- 005
- 20250618090639.0
- 007
- ta
- 008
- 140704s2013 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/HJH.0b013e328362adb3 $2 doi
- 035 __
- $a (PubMed)24107733
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Behuliak, Michal $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic bInstitute of Pharmacology, Faculty of Medicine, Comenius University, Bratislava, Slovakia *Michal Behuliak and Mária Pintérová contributed equally to the writing of this article. $7 xx0196023
- 245 10
- $a Ca2+ sensitization and Ca2+ entry in the control of blood pressure and adrenergic vasoconstriction in conscious Wistar-Kyoto and spontaneously hypertensive rats / $c M. Behuliak, M. Pintérová, M. Bencze, M. Petrová, S. Líšková, P. Karen, J. Kuneš, I. Vaněčková, J. Zicha,
- 520 9_
- $a BACKGROUND: Calcium entry through nifedipine-sensitive L-type voltage-dependent calcium channels (L-VDCC) is augmented in spontaneously hypertensive rats (SHR) characterized by enhanced sympathetic vasoconstriction. However, the changes of calcium sensitization mediated by RhoA/Rho kinase pathway are less understood. METHODS AND RESULTS: The participation of calcium entry and calcium sensitization in the control of blood pressure (BP) and vascular contraction was studied in SHR and normotensive Wistar-Kyoto (WKY) rats. The acute administration of fasudil (Rho kinase inhibitor) caused BP decrease which lasted longer in SHR. Fasudil also attenuated adrenergic contraction in femoral or mesenteric arteries of WKY and SHR. BP reduction elicited by fasudil in WKY was more pronounced than that induced by L-VDCC blocker nifedipine (-33±2 vs. -15±3% of baseline BP, P<0.001), whereas both inhibitors were similarly effective in SHR (-36±4 vs. -41±2%). Fasudil pretreatment also attenuated BP elevation elicited by L-VDCC agonist BAY K8644 more in WKY than in SHR (-63±4 vs. -42±5%, P<0.001), indicating reduced calcium sensitization in SHR. Moreover, fasudil pretreatment shifted norepinephrine dose-response curves to the right more in WKY than in SHR. The additional nifedipine pretreatment shifted these curves further to the right but this shift was more pronounced in SHR than in WKY. Thus adrenergic vasoconstriction is more dependent on L-VDCC in SHR and on RhoA/Rho kinase pathway in WKY rats. CONCLUSION: Ca sensitization mediated by RhoA/Rho kinase pathway is attenuated in SHR compared with normotensive WKY rats. This might be a part of the compensation for enhanced Ca entry through L-VDCC in genetic hypertension.
- 650 _2
- $a 1-(5-isochinolinsulfonyl)-2-methylpiperazin $x analogy a deriváty $x farmakologie $7 D019307
- 650 _2
- $a 3-pyridinkarboxylová kyselina, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)fenyl)-, methyleste $x farmakologie $7 D001498
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a krevní tlak $7 D001794
- 650 _2
- $a vápník $x metabolismus $7 D002118
- 650 _2
- $a agonisté vápníkových kanálů $x farmakologie $7 D002120
- 650 _2
- $a vápníkové kanály - typ L $x metabolismus $7 D020746
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a arteriae mesentericae $x účinky léků $7 D008638
- 650 _2
- $a nifedipin $x farmakologie $7 D009543
- 650 _2
- $a oxid dusnatý $x metabolismus $7 D009569
- 650 _2
- $a noradrenalin $x farmakologie $7 D009638
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani inbrední SHR $7 D011918
- 650 _2
- $a potkani inbrední WKY $7 D011921
- 650 _2
- $a adrenergní receptory $x metabolismus $7 D011941
- 650 _2
- $a teplota $7 D013696
- 650 _2
- $a vazokonstrikce $x účinky léků $7 D014661
- 650 _2
- $a kinázy asociované s rho $x antagonisté a inhibitory $x metabolismus $7 D054460
- 650 _2
- $a rhoA protein vázající GTP $x metabolismus $7 D020742
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pintérová, Mária
- 700 1_
- $a Bencze, Michal
- 700 1_
- $a Petrová, Miriam
- 700 1_
- $a Líšková, Silvia
- 700 1_
- $a Karen, Petr
- 700 1_
- $a Kuneš, Jaroslav
- 700 1_
- $a Vaněčková, Ivana
- 700 1_
- $a Zicha, Josef
- 773 0_
- $w MED00002723 $t Journal of hypertension $x 1473-5598 $g Roč. 31, č. 10 (2013), s. 2025-35
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24107733 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140704 $b ABA008
- 991 __
- $a 20250618090630 $b ABA008
- 999 __
- $a ok $b bmc $g 1031393 $s 862641
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 31 $c 10 $d 2025-35 $i 1473-5598 $m Journal of hypertension $n J Hypertens $x MED00002723
- LZP __
- $a Pubmed-20140704